Defined as breast cancer that lacks expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2), TNBC is an aggressive histological subtype of breast cancer where women present with high grade, advanced disease. Here, PGR is linked to breast carcinoma.